PATENT CLAIM ANALYSIS

Application Number: 16228835
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-06
Patent Classification: ["514", "253120"]

Abstract:
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the neurokinin (NK 1 ) receptor. The compounds have the general formula (I):

Claim (Index 5):
The compound of  claim 1 , or a pharmaceutically acceptable salt thereof, wherein the compound of formula (I) has a structure of formula (II): where Q and R\u2033 are each independently selected from the group consisting of C, O, S, and N, each optionally independently substituted with one or more independent R 103  substituents; R 7  is selected from the group selected from hydrogen, alkoxy, alkoxyalkyl, \u2014OR 101 , hydroxy, hydroxyalkyl, amino, alkyl, alkenyl, cycloalkyl and halogen, each optionally independently substituted with one or more independent R 103  substituents; s is 0, 1, 2, 3 or 4; and all other radicals are defined according to formula (I).

Metadata:
- Claim Count in Document: 17.0
- Percentile: 98.0
- Lexical Diversity: 1.19355
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15194984', '15874325', '14360991', '12637719', '11582293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8260791263922475
- 35 USC 102 Novelty (BERT): 0.5417089683399091
- Combined Prediction Score: 0.7976421105870136
- Mean Citation Score: 329.305366
- Max Citation Score: 397.34216
- Similarity Product: 324.36083963829986

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test